Docket Number:28T-1060428
Inventor:Shang-Cheng Hung
IP Status:Know how (Trade secret)
Abstract:
Numerous biomolecules possess α-D-glucosamine as structural component, such as heparin or heparan sulfate. However, chemical glycosylations aimed at this backbone are usually not easily attained without generating the unwanted β-isomer. We report herein a versatile approach in affording highly α-stereoselectivity built upon a carefully selected set of orthogonal protecting groups on a D-glucosaminyl donor. The excellent stereoselectivity provided by the protecting group combination was found independent of leaving groups and activators.
Fields of Application:
glycan drug synthesis
Advantages when compared to the existing technologies:
Organic synthesis of glycan drugs
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you
